Heart failure drug shows promise for Non-Diabetic patients
Disease control
Completed
This study tested whether the drug sotagliflozin can improve heart function in people with a type of heart failure called HFpEF who do not have diabetes. Eighty-eight participants took either the drug or a placebo for six months. Researchers used heart scans and exercise tests to…
Phase: PHASE4 • Sponsor: Juan Badimon • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC